N6-Methyladenosine Modifications in Pulmonary Hypertension

Area of Science:

• Molecular Biology
• Epigenetics
• Cardiovascular Research

Background:

• N6-methyladenosine (m6A) is the most prevalent reversible RNA methylation modification in eukaryotes.
• m6A regulates fundamental cellular processes including differentiation, self-renewal, invasion, and apoptosis via protein synthesis.
• m6A modification is implicated in disease progression and pulmonary vascular remodeling in pulmonary hypertension.

Purpose of the Study:

• To review recent advances in m6A RNA methylation research concerning pulmonary hypertension.
• To explore the regulatory role of m6A modifications in the development and progression of pulmonary hypertension.

Main Methods:

• Literature review of current research on m6A RNA methylation and pulmonary hypertension.
• Analysis of studies investigating the mechanisms of m6A regulation in cardiovascular diseases.

Main Results:

• m6A modification influences key cellular processes relevant to pulmonary hypertension.
• Evidence suggests a significant role for m6A in pulmonary hypertension pathogenesis and progression.
• The specific impact of m6A on pulmonary hypertension remains under-investigated.

Conclusions:

• m6A RNA methylation is a critical factor in pulmonary hypertension.
• Further research into m6A modifications is warranted to understand and potentially treat pulmonary hypertension.